NO178576C - Analogifremgangsmåte til fremstilling av terapeutisk aktive derivater av benzimidazol - Google Patents

Analogifremgangsmåte til fremstilling av terapeutisk aktive derivater av benzimidazol

Info

Publication number
NO178576C
NO178576C NO912669A NO912669A NO178576C NO 178576 C NO178576 C NO 178576C NO 912669 A NO912669 A NO 912669A NO 912669 A NO912669 A NO 912669A NO 178576 C NO178576 C NO 178576C
Authority
NO
Norway
Prior art keywords
radical
benzimidazole
aryl
halogen
represent
Prior art date
Application number
NO912669A
Other languages
English (en)
Norwegian (no)
Other versions
NO912669D0 (no
NO912669L (no
NO178576B (no
Inventor
Maria Rosa Cuberes-Altisent
Jordi Frigola-Constansa
Juan Pares-Corominas
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO912669D0 publication Critical patent/NO912669D0/no
Publication of NO912669L publication Critical patent/NO912669L/no
Publication of NO178576B publication Critical patent/NO178576B/no
Publication of NO178576C publication Critical patent/NO178576C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO912669A 1990-07-26 1991-07-08 Analogifremgangsmåte til fremstilling av terapeutisk aktive derivater av benzimidazol NO178576C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9009563A FR2665161B1 (fr) 1990-07-26 1990-07-26 Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.

Publications (4)

Publication Number Publication Date
NO912669D0 NO912669D0 (no) 1991-07-08
NO912669L NO912669L (no) 1992-01-27
NO178576B NO178576B (no) 1996-01-15
NO178576C true NO178576C (no) 1996-04-24

Family

ID=9399131

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912669A NO178576C (no) 1990-07-26 1991-07-08 Analogifremgangsmåte til fremstilling av terapeutisk aktive derivater av benzimidazol

Country Status (25)

Country Link
US (1) US5182280A (de)
EP (1) EP0468884B1 (de)
JP (1) JPH0832703B2 (de)
KR (1) KR0183028B1 (de)
CN (1) CN1030915C (de)
AT (1) ATE131822T1 (de)
AU (1) AU638857B2 (de)
CA (1) CA2047880A1 (de)
CZ (1) CZ280185B6 (de)
DE (1) DE69115588T2 (de)
DK (1) DK0468884T5 (de)
ES (1) ES2038074B1 (de)
FR (1) FR2665161B1 (de)
GR (1) GR3019352T3 (de)
HU (2) HU215109B (de)
MX (1) MX9100377A (de)
NO (1) NO178576C (de)
NZ (1) NZ239104A (de)
PL (1) PL167222B1 (de)
PT (1) PT98409B (de)
RO (1) RO109736B1 (de)
RU (1) RU2024519C1 (de)
TW (1) TW314518B (de)
YU (1) YU48077B (de)
ZA (1) ZA915839B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674856B1 (fr) * 1991-04-05 1993-07-30 Esteve Labor Dr Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.
FR2701260B1 (fr) * 1993-02-05 1995-05-05 Esteve Labor Dr Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments.
US5681954A (en) * 1993-05-14 1997-10-28 Daiichi Pharmaceutical Co., Ltd. Piperazine derivatives
JP3338913B2 (ja) * 1993-06-29 2002-10-28 大鵬薬品工業株式会社 テトラゾール誘導体
IL113472A0 (en) 1994-04-29 1995-07-31 Lilly Co Eli Non-peptidyl tachykinin receptor antogonists
FR2727865B1 (fr) * 1994-12-08 1997-07-18 Esteve Labor Dr Utilisation des derives de 2-(4-(azolybutyl)-piperazinyl- (methyl))-benzimidazole et analogues ainsi que de leurs sels, pour la preparation de medicaments destines au traitement ou a la prophylaxie de l'asthme
FR2731618B1 (fr) * 1995-03-14 1997-08-01 Esteve Labor Dr Composition ophtalmique topique comprenant un derive de 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole, notamment pour le traitement de la conjonctivite allergique
EP1165013A4 (de) * 1999-03-03 2002-08-07 Merck & Co Inc Inhibitoren der phenyl-protein-transferase
US20020169166A1 (en) * 2001-03-09 2002-11-14 Cowart Marlon D. Benzimidazoles that are useful in treating sexual dysfunction
US6960589B2 (en) 2001-03-09 2005-11-01 Abbott Laboratories Benzimidazoles that are useful in treating sexual dysfunction
US7022728B2 (en) 2001-03-09 2006-04-04 Abbott Laboratories Benzimidazoles that are useful in treating male sexual dysfunction
WO2003101994A1 (en) * 2002-05-29 2003-12-11 Abbott Laboratories Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
US7057042B2 (en) 2002-05-29 2006-06-06 Abbott Laboratories Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
AU2003282510A1 (en) * 2002-10-11 2004-05-04 Bristol-Myers Squibb Company Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
CN101022728B (zh) * 2004-03-25 2012-08-08 詹森药业有限公司 咪唑化合物
CN101089000B (zh) 2006-06-16 2011-01-05 北京大学 螺环哌嗪季铵盐类化合物及其制备方法和应用
JP5820822B2 (ja) * 2010-04-26 2015-11-24 大日本住友製薬株式会社 リン酸塩を用いる第四級アンモニウム塩の製造法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL272996A (de) * 1960-12-28
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
US4179505A (en) * 1977-03-30 1979-12-18 Janssen Pharmaceutica N.V. 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
JPS59199679A (ja) * 1983-04-27 1984-11-12 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
DE3336409A1 (de) * 1983-10-06 1985-04-18 Ludwig Heumann & Co GmbH, 8500 Nürnberg Chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4684654A (en) * 1985-08-14 1987-08-04 American Cyanamid Company 3-heteroalkyl-2,4-quinzaolinediones
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
IT1226100B (it) * 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
US4902687A (en) * 1989-03-27 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.

Also Published As

Publication number Publication date
TW314518B (de) 1997-09-01
CN1058404A (zh) 1992-02-05
PL291247A1 (en) 1992-03-09
HUT58320A (en) 1992-02-28
YU48077B (sh) 1997-01-08
NO912669D0 (no) 1991-07-08
HU912518D0 (en) 1992-01-28
JPH04234387A (ja) 1992-08-24
HU211599A9 (en) 1995-12-28
CS235191A3 (en) 1992-04-15
CZ280185B6 (cs) 1995-11-15
AU8128091A (en) 1992-01-30
NO912669L (no) 1992-01-27
GR3019352T3 (en) 1996-06-30
PL167222B1 (pl) 1995-08-31
KR0183028B1 (ko) 1999-05-01
JPH0832703B2 (ja) 1996-03-29
ZA915839B (en) 1992-04-29
NO178576B (no) 1996-01-15
FR2665161A1 (fr) 1992-01-31
RU2024519C1 (ru) 1994-12-15
CN1030915C (zh) 1996-02-07
DK0468884T5 (da) 1996-09-30
ES2038074B1 (es) 1994-02-01
ES2038074A1 (es) 1993-07-01
PT98409A (pt) 1992-06-30
PT98409B (pt) 1999-01-29
MX9100377A (es) 1992-02-28
RO109736B1 (ro) 1995-05-30
ATE131822T1 (de) 1996-01-15
US5182280A (en) 1993-01-26
DE69115588T2 (de) 1996-06-20
YU123691A (sh) 1994-05-10
AU638857B2 (en) 1993-07-08
KR920002587A (ko) 1992-02-28
DE69115588D1 (de) 1996-02-01
HU215109B (hu) 2000-04-28
FR2665161B1 (fr) 1992-11-27
EP0468884A1 (de) 1992-01-29
EP0468884B1 (de) 1995-12-20
NZ239104A (en) 1993-12-23
CA2047880A1 (fr) 1992-01-27

Similar Documents

Publication Publication Date Title
NO178576C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive derivater av benzimidazol
DE69132497D1 (de) Benzimidazolderivate, verfahren zu deren herstellung und deren anwendung
GR3017643T3 (en) Antihistaminic and non-sedative derivatives of benzimidazol, process for their preparation and their medicinal use.
NO163568C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
KR950704301A (ko) 항미생물제 5-히드라지노-퀴놀론 유도체(antimicrobial 5-hydrazino-quinolone derivatives)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2003